The Food and Drug Administration has tapped a former executive from a health artificial intelligence company to lead its digital health center.
Rick Abramson, formerly a chief medical officer at a subsidiary of
Harrison.ai
, which develops AI products to interpret radiological images, is the new director of the Digital Health Center of Excellence, according to two people familiar with the appointment. The move comes as the agency wrestles with the future regulation of AI.
Abramson has since last summer been working as a senior adviser in the commissioner’s office. In January, the agency
announced
it would soften the regulation of AI products that support clinician decision-making, and allow more wellness products to avoid FDA review. Three agency employees told STAT at the time that the push to deregulate was led by Abramson and two other officials in the commissioner’s office: Jared Seehafer and Shantanu Nundy.
Continue to STAT+ to read the full story…
— Source: STAT News (https://www.statnews.com/2026/02/19/fda-appoints-new-digital-health-center-director/)
